U.S.
-
Biologics
Kuros Biosciences Reports Continued Increase in MagnetOs U.S. Sales
Ad hoc announcement pursuant to Article 53 of the SIX listing rules MagnetOs U.S. YTD sales increase 119% in 2021…
Read More » -
Spine
Medacta Announces First U.S. Surgery with the New M.U.S.T. LT System in Minimally Invasive Spine Surgery
Media release CASTEL SAN PIETRO, 28 April 2021 – Medacta announced today the first surgery utilizing its M.U.S.T.(R) LT, following clearance by the…
Read More » -
Financial
US medical devices industry M&A deals total $11.67bn in Q4 2020
Total medical devices industry M&A deals in Q4 2020 worth $11.67bn were announced in the US, according to GlobalData’s deals…
Read More » -
Spine
Synergy Disc® Announces Enrollment of First Patient in US IDE Clinical Trial
January 29, 2021 LOUISVILLE, Colo.–(BUSINESS WIRE)–Synergy Disc Replacement Ltd., a Colorado-based spinal medical device company and wholly owned subsidiary of…
Read More » -
Financial
Hyprevention Raises New Financing to Commercialize Spinal Implant Product V-STRUT© in the USA.
September 28, 2020 PESSAC, France–(BUSINESS WIRE)–Hyprevention has raised new financing to support the V-STRUT© Vertebral Implant product. The financing will…
Read More » -
Regulatory
Safe Orthopaedics receives 510k approval from the FDA for the sale of its 2nd Generation of SteriSpineTM PS in the United States
Eragny-sur-Oise, France, August 10th à 6.00 PM CEST – Safe Orthopaedics (FR0013467123 – ALSAF), a company specializing in the design and…
Read More » -
Extremities
OSSIO Announces U.S. Launch and First Commercial Use of the OSSIOfiber® Trimmable Fixation Nail System for Broad Utilization in Foot/Ankle and Hand/Wrist Procedures
July 22, 2020 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced the U.S. launch and first commercial use…
Read More » -
Spine
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partners
January 13, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More »